Web Results

Gilead Sciences, Inc. v. Merck & Co, Inc. et al - RPX Search

search.rpxcorp.com/lit/candce-269618-gilead-sciences-v-merck

Gilead Sciences, Inc. v. Merck & Co, Inc. et al. 5:13-cv-04057; Filed: 08/30/2013; Closed: 06/06/2016; Latest Docket Entry: 12/06/2016; PACER. Thank you for ...

Gilead Sciences, Inc. v. Merck & Co, Inc. et al :: Justia Dockets ...

dockets.justia.com/docket/california/candce/3:2013cv04057/269618

Aug 30, 2013 ... Patent case filed on August 30, 2013 in the California Northern District Court.

COLICCHIO v. MERCK & CO., INC. et al, No. 2:2008cv03593 ...

law.justia.com/cases/federal/district-courts/new-jersey/njdce/2:2008cv03593/217059/103/

COLICCHIO v. MERCK & CO., INC. et al, No. 2:2008cv03593 - Document 103 ( D.N.J. 2012) case opinion from the District of New Jersey U.S. Federal District ...

Gilead Sciences, Inc. v. Merck & Co, Inc. et al - Law360

www.law360.com/cases/5362954575127729f8000001

Aug 11, 2016 ... Parties, docket activity and news coverage of federal case Gilead Sciences, Inc. v . Merck & Co, Inc. et al, case number 5:13-cv-04057, from ...

Merck & Co., Inc. v. Reynolds - SCOTUSblog

www.scotusblog.com/case-files/cases/merck-co-inc-v-richard-reynolds-2/

Apr 27, 2010 ... Merck & Co., Inc. v. ... Joint Appendix Volume I · Brief for Respondent Richard Reynolds, et al. Reply Brief for Petitioner Merck & Co. ... Brief for Dr. Harlan M. Krumholz and Dr. Joseph S. Ross in Support of Respondents ...

Merck & Co. v. Reynolds - Supreme Court

www.supremecourt.gov/opinions/09pdf/08-905.pdf

Apr 27, 2010 ... Detroit Timber & Lumber Co., 200 U. S. 321, 337. SUPREME COURT OF THE UNITED STATES. Syllabus. MERCK & CO., INC., ET AL. v.

What have we learnt from Vioxx? - NCBI - National Institutes of Health

www.ncbi.nlm.nih.gov/pmc/articles/PMC1779871/

Jan 20, 2007 ... Harlan M Krumholz, Harold H Hines Junior professor of medicine and ... Rofecoxib (Vioxx) was introduced by Merck in 1999 as an effective, safer ..... Letter re: financial disclosure for Merck and Co, Inc sponsored protocol entitled: ... Deborah Shapiro, et al. re: fw: for review [peer]: 2001-ms-2470 (full paper) .....

Pooled Analysis of Rofecoxib Placebo-Controlled Clinical Trial ...

jamanetwork.com/journals/jamainternalmedicine/fullarticle/1108579

Nov 23, 2009 ... Merck & Co Inc] March9 2000 ... Bresalier RSSandler RSQuan H et al. ... COX-2 inhibitor rofecoxib vs ibuprofen in patients with osteoarthritis.

Pooled Analysis of Rofecoxib Placebo-Controlled Clinical Trial Data ...

www.ncbi.nlm.nih.gov/pmc/articles/PMC2830805/

Merck, the maker of rofecoxib, promoted it as a safer alternative to traditional .... to rofecoxib at the request of plaintiffs and against Merck and Co., Inc. While the authors .... Our analysis builds upon the prior work of Jüni et al., published shortly after ..... of the COX-2 inhibitor rofecoxib vs ibuprofen in patients with osteo...

Home Use of a Bihormonal Bionic Pancreas Improves Glycemic ...

www.endocrineweb.com/professional/meetings/home-use-bihormonal-bionic-pancreas-improves-glycemic-control-reduces-hypoglyc

Jun 20, 2016 ... They evaluated a bihormonal pump vs conventional insulin pump therapy in adults .... Elkhatib F, Buckingham BA, Buse JB, Harlan DM, et al. ... Therapeutics, Inc., GI Dynamics, Inc., Lexicon Pharmaceuticals, Inc., Merck & Co., ...